1. Home
  2. FLNC vs NVAX Comparison

FLNC vs NVAX Comparison

Compare FLNC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluence Energy Inc.

FLNC

Fluence Energy Inc.

HOLD

Current Price

$9.96

Market Cap

1.8B

Sector

Miscellaneous

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.59

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNC
NVAX
Founded
2018
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.3B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
FLNC
NVAX
Price
$9.96
$9.59
Analyst Decision
Hold
Hold
Analyst Count
17
9
Target Price
$15.71
$11.33
AVG Volume (30 Days)
5.3M
4.9M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
N/A
Revenue
$2,262,830,000.00
$1,123,479,000.00
Revenue This Year
$51.23
N/A
Revenue Next Year
$21.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
64.69
52 Week Low
$6.79
$6.20
52 Week High
$33.51
$11.85

Technical Indicators

Market Signals
Indicator
FLNC
NVAX
Relative Strength Index (RSI) 33.04 53.12
Support Level N/A $9.14
Resistance Level $15.89 $10.26
Average True Range (ATR) 0.51 0.63
MACD 0.04 0.03
Stochastic Oscillator 3.62 42.78

Price Performance

Historical Comparison
FLNC
NVAX

About FLNC Fluence Energy Inc.

Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: